Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Makishima

Showing results (631-640 of 737) with videos related to

Pageof 74
Sort By:
International Journal of Hematology|May 21, 2025
Whole-genome sequencing reveals genetic backgrounds in Japanese patients with hemophagocytic lymphohistiocytosis treated with the HLH-2004 protocolRyu Yanagisawa, Manabu Wakamatsu, Dan Tomomasa, et al.
Immunological Medicine|July 4, 2026
Risk factors for adverse events or use of high-potency corticosteroids in non-infectious uveitis: a Japan claims database study (J-CAT2)Sentaro Kusuhara, Koh-Hei Sonoda, Toshikatsu Kaburaki, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 29, 2012
Topography, clinical, and genomic correlates of 5q myeloid malignancies revisitedAndres Jerez, Lukasz P Gondek, Anna M Jankowska, et al.
Blood|February 25, 2011
CBL, CBLB, TET2, ASXL1, and IDH1/2 mutations and additional chromosomal aberrations constitute molecular events in chronic myelogenous leukemiaHideki Makishima, Anna M Jankowska, Michael A McDevitt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 11, 2009
Mutations of e3 ubiquitin ligase cbl family members constitute a novel common pathogenic lesion in myeloid malignanciesHideki Makishima, Heather Cazzolli, Hadrian Szpurka, et al.
Journal of Radiation Research|June 3, 2025
Radiotherapy treatment planning for esophageal cancer: JASTRO guidelines 2024 for radiotherapy treatment planningKeiichi Jingu, Keiji Nihei, Yoshinori Ito, et al.
British Journal of Haematology|November 30, 2011
Molecular lesions in childhood and adult acute megakaryoblastic leukaemiaAsahito Hama, Hideki Muramatsu, Hideki Makishima, et al.
Blood|February 11, 2012
Mutations in the spliceosome machinery, a novel and ubiquitous pathway in leukemogenesisHideki Makishima, Valeria Visconte, Hirotoshi Sakaguchi, et al.
Blood|August 26, 2011
Clonal drift demonstrates unexpected dynamics of the T-cell repertoire in T-large granular lymphocyte leukemiaMichael J Clemente, Marcin W Wlodarski, Hideki Makishima, et al.
American Journal of Hematology|January 23, 2016
Impact of allogeneic hematopoietic cell transplant in patients with myeloid neoplasms carrying spliceosomal mutationsBetty Ky Hamilton, Valeria Visconte, Xuefei Jia, et al.
Pageof 74

Showing results (631-640 of 737) with videos related to

Sort By:
Pageof 74
International Journal of Hematology|May 21, 2025
Whole-genome sequencing reveals genetic backgrounds in Japanese patients with hemophagocytic lymphohistiocytosis treated with the HLH-2004 protocolRyu Yanagisawa, Manabu Wakamatsu, Dan Tomomasa, et al.
Immunological Medicine|July 4, 2026
Risk factors for adverse events or use of high-potency corticosteroids in non-infectious uveitis: a Japan claims database study (J-CAT2)Sentaro Kusuhara, Koh-Hei Sonoda, Toshikatsu Kaburaki, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 29, 2012
Topography, clinical, and genomic correlates of 5q myeloid malignancies revisitedAndres Jerez, Lukasz P Gondek, Anna M Jankowska, et al.
Blood|February 25, 2011
CBL, CBLB, TET2, ASXL1, and IDH1/2 mutations and additional chromosomal aberrations constitute molecular events in chronic myelogenous leukemiaHideki Makishima, Anna M Jankowska, Michael A McDevitt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 11, 2009
Mutations of e3 ubiquitin ligase cbl family members constitute a novel common pathogenic lesion in myeloid malignanciesHideki Makishima, Heather Cazzolli, Hadrian Szpurka, et al.
Journal of Radiation Research|June 3, 2025
Radiotherapy treatment planning for esophageal cancer: JASTRO guidelines 2024 for radiotherapy treatment planningKeiichi Jingu, Keiji Nihei, Yoshinori Ito, et al.
British Journal of Haematology|November 30, 2011
Molecular lesions in childhood and adult acute megakaryoblastic leukaemiaAsahito Hama, Hideki Muramatsu, Hideki Makishima, et al.
Blood|February 11, 2012
Mutations in the spliceosome machinery, a novel and ubiquitous pathway in leukemogenesisHideki Makishima, Valeria Visconte, Hirotoshi Sakaguchi, et al.
Blood|August 26, 2011
Clonal drift demonstrates unexpected dynamics of the T-cell repertoire in T-large granular lymphocyte leukemiaMichael J Clemente, Marcin W Wlodarski, Hideki Makishima, et al.
American Journal of Hematology|January 23, 2016
Impact of allogeneic hematopoietic cell transplant in patients with myeloid neoplasms carrying spliceosomal mutationsBetty Ky Hamilton, Valeria Visconte, Xuefei Jia, et al.
Pageof 74